Skip to content

PSX Pharmaceuticals

HALEON Haleon Pakistan Limited

Latest results: FY2025 · Dec 2025 Q2 FY2026 · Apr – Jun 2026

FY2025 revenue Rs 43.1 bn (+15.9%), profit Rs 6.4 bn (+39.2%). Dividend paid 2 years in a row.

Last close · 13 Nov 2026

Rs 697.10 ▲ 1.11 (+0.16%)

▼ 14.7% 1 year

15 Oct 22 Oct 28 Oct 3 Nov 11 Nov Jun Jul Aug Sep Oct Dec Feb May Jul Oct 2022 2023 2024 2025 2026
650.0052-week range1,010.00
Market cap
Rs 81.6 bn
P/E
12.4×
TTM to Jun 2026
Sector 12.6×
P/B
5.02×
Quarter to Jun 2026
Sector 3.11× · higher
Dividend yield
4.3%
FY2025
Payers 4.7% · lower
ROE
47.6%
FY2025
Sector 21.7% · higher
EPS
Rs 56.41
TTM to Jun 2026
Book value / share
Rs 138.76
Quarter to Jun 2026

Fundamentals

HALEON at a glance

Revenue · FY2025

Rs 43.1 bn

▲ 15.9% year on year

Profit attributable to shareholders · FY2025

Rs 6.4 bn

▲ 39.2% year on year

EPS – basic (Rs) · FY2025

Rs 54.45

▲ 39.2% year on year

Dividend per share (Rs) · FY2025

Rs 30.00

▲ 50.0% year on year

Net margin · FY2025

14.8%

+2.5 pts year on year

Debt to equity · FY2025

1.7%

-0.4 pts year on year

Price performance

HALEON returns

Close Rs 697.10
13 Nov 2026

Period Return Rs
MTD +5.8% −1.1 pts vs KSE +38.30
3M −6.8% −5.6 pts vs KSE −51.21
6M −8.5% −14.8 pts vs KSE −65.05
YTD −16.4% −18.5 pts vs KSE −136.22
1Y −14.7% −25.5 pts vs KSE −120.43
Long term
3Y +329.8% +62.6% a year +115.1 pts vs KSE +534.89
5Y +171.0% +22.1% a year −117.8 pts vs KSE +439.83

Price return from the last close before each period; the fiscal year ends 31 December, so year to date is also fiscal year to date. Dividends are not included.

Haleon Pakistan Limited in brief

Haleon Pakistan Limited (HALEON) reported revenue of Rs 43.1 bn for FY2025 (Jan – Dec 2025), up 15.9% from FY2024.

Profit attributable to shareholders was Rs 6.4 bn (EPS Rs 54.45), up 39.2%, a net margin of 14.8%.

It declared a dividend of Rs 30.00 per share for FY2025.

The balance sheet showed net cash of Rs 7.4 bn.

Return on equity was 47.6%.

Over the last five years revenue grew at a compound 16.8% a year.

At Rs 697.10 (close on 13 Nov 2026) the shares trade at 12.4× earnings (TTM to Jun 2026) and 5.02× book value, with a dividend yield of 4.3%.

Scorecard vs Pharmaceuticals

14 companies
Growth
Average
16.2%
Profitability
Above average
14.8%
Financial health
Above average
1.7%
Valuation
Average
12.4×
Dividends
Above average
4.3%

Ratings place the company in its sector: growth (3-year revenue growth), profitability (net margin; return on equity for banks, insurers and finance companies), financial health (debt to equity, industrial companies), valuation (P/E at today's price) and dividends (yield at today's price). Five dots = top fifth. Rated within the sector when at least four companies report the figure, otherwise against all PSX companies of the same type (marked vs PSX). Information, not investment advice.

Ownership

International funds holding HALEON

1 of the international funds we track lists HALEON in its latest portfolio report, shown as reported with the report's date.

Funds holding
1
Combined shares
417,257
as reported
Combined stake
0.36%
of HALEON's shares
Latest reports
0 added 1 reduced
Mar 2021 – Mar 2021
Matthews Emerging Asia Fund US Matthews International Capital Management LLC 417,257 0.36% ▼ −840,300 Mar 2021 older report

As reported in each fund's latest portfolio report listing HALEON; funds report on their own dates, shown on each row. These are the international funds we track, not the full foreign shareholding. Updated monthly.

Corporate

HALEON announcements & payouts

All HALEON announcements →
29 Oct 2026 · 16:25
Result · Nine months to 30 Sep 2026
Profit after tax
Rs 4,728.4 mn
EPS
Rs 40.40 +3.1%
EPS a year earlier
Rs 39.18
27 Aug 2026 · 15:11
Result · Half year to 30 Jun 2026 Cash 100% · Rs 10.00 · Interim 1
Profit after tax
Rs 3,201.0 mn
EPS
Rs 27.35 +7.8%
EPS a year earlier
Rs 25.38

Book closure 8 Sep – 9 Sep 2026 · Buy by Thu 3 Sep (est.) for the payout

30 Apr 2026 · 10:13
Result · First quarter to 31 Mar 2026
Profit after tax
Rs 1,524.8 mn
EPS
Rs 13.03 +13.2%
EPS a year earlier
Rs 11.51
3 Mar 2026 · 14:17
Result · Full year to 31 Dec 2025 Cash 150% · Rs 15.00 · Final AGM 28 Apr
Profit after tax
Rs 6,373.2 mn
EPS
Rs 54.45 +39.2%
EPS a year earlier
Rs 39.11

Book closure 22 Apr – 28 Apr 2026 · Buy by Fri 17 Apr (est.) for the payout

Financial highlights

HALEON financial results

HALEON annual financial highlights (Rs bn)
Rs bn FY2025 Jan – Dec 2025 FY2024 Jan – Dec 2024 FY2023 Jan – Dec 2023 FY2022 Jan – Dec 2022 FY2021 Jan – Dec 2021 FY2020 Jan – Dec 2020 FY2019 Jan – Dec 2019 FY2018 * Jan – Dec 2018 FY2017 Jan – Dec 2017 FY2016 * Jan – Dec 2016
Revenue 43.1 37.2 31.6 27.5 24.2 19.8 16.3 14.9 8.3 5.4
Gross profit 16.9 12.8 6.4 4.8 6.7 5.3 5.0 4.4 3.1 1.5
Operating profit 10.0 6.7 1.7 1.0 2.9 1.8 1.9 1.6 1.1 0.8
Profit after tax 6.4 4.6 1.0 0.3 2.1 1.3 1.3 1.1 0.7 0.5
Profit attributable to shareholders 6.4 4.6 1.0 0.3 2.1 1.3 1.3 1.1 0.7 0.5
EPS – basic (Rs) Rs 54.45 39.11 8.51 2.78 18.23 10.78 10.74 9.18 7.40 7.60
Dividend per share (Rs) Rs 30.00 20.00 0.00 0.00 0.00 5.00 5.00 5.00 5.00 0.00
Total assets 27.2 21.8 18.2 15.1 13.9 11.0 9.0 8.0 4.0 2.9
Total equity 14.8 12.0 8.0 7.0 6.7 5.2 4.5 3.8 2.3 1.6
Total debt 0.3 0.2 0.2 0.2 0.0 0.0 0.8 1.6 — —
Net cash from operating activities 6.3 7.7 2.6 1.2 1.8 2.9 1.4 (0.3) 0.6 1.0
Capital expenditure (2.0) (3.2) (1.8) (0.5) (0.5) (0.9) (0.5) (0.3) (0.0) (0.1)
Free cash flow (operating cash flow − capex) 4.3 4.5 0.8 0.7 1.2 2.1 0.8 (0.7) 0.6 0.9
HALEON quarterly financial highlights (Rs bn)
Rs bn TTM to Jun 2026 Q2 FY2026 Apr – Jun 2026 Q1 FY2026 Jan – Mar 2026 Q4 FY2025 Oct – Dec 2025 Q3 FY2025 Jul – Sep 2025 Q2 FY2025 Apr – Jun 2025 Q1 FY2025 Jan – Mar 2025 Q4 FY2024 Oct – Dec 2024 Q3 FY2024 Jul – Sep 2024
Revenue 41.1 10.1 9.6 10.9 10.6 11.6 10.0 9.7 9.8
Gross profit 17.5 5.0 3.8 4.5 4.3 4.7 3.4 3.6 3.7
Operating profit 10.7 2.5 2.4 3.1 2.7 2.8 2.2 2.1 2.3
Profit after tax 6.6 1.7 1.5 1.8 1.6 1.6 1.3 1.4 1.3
Profit attributable to shareholders 6.6 1.7 1.5 1.8 1.6 1.6 1.3 1.4 1.3
EPS – basic (Rs) Rs 56.41 14.32 13.03 15.27 13.80 13.87 11.51 11.75 11.36
Dividend per share (Rs) Rs 30.00 10.00 0.00 15.00 5.00 10.00 0.00 15.00 5.00
Total assets 30.5 30.5 29.9 27.2 25.2 25.4 24.8 21.8 23.9
Total equity 16.2 16.2 14.6 14.8 13.6 13.2 11.6 12.0 11.2
Total debt 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.2 0.2
Net cash from operating activities 3.9 (0.0) 0.3 3.3 0.3 1.0 1.7 2.3 1.8
Capital expenditure (2.3) (0.3) (0.4) (1.1) (0.4) (0.4) (0.1) (1.5) (0.6)
Free cash flow (operating cash flow − capex) 1.6 (0.4) (0.1) 2.2 (0.1) 0.6 1.6 0.7 1.3

Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets. Free cash flow and book value per share are calculated by Smart Money; TTM = the latest four quarters. Updated 17 Oct 2026.

HALEON charts

Revenue and profit Revenue Profit attributable
Revenue and profit Rs 43 bn Revenue FY16: Rs 5.4 bn Profit attributable FY16: Rs 545.5 mn FY16 Revenue FY17: Rs 8.3 bn Profit attributable FY17: Rs 706.8 mn FY17 Revenue FY18: Rs 14.9 bn Profit attributable FY18: Rs 1.1 bn FY18 Revenue FY19: Rs 16.3 bn Profit attributable FY19: Rs 1.3 bn FY19 Revenue FY20: Rs 19.8 bn Profit attributable FY20: Rs 1.3 bn FY20 Revenue FY21: Rs 24.2 bn Profit attributable FY21: Rs 2.1 bn FY21 Revenue FY22: Rs 27.5 bn Profit attributable FY22: Rs 325.4 mn FY22 Revenue FY23: Rs 31.6 bn Profit attributable FY23: Rs 995.6 mn FY23 Revenue FY24: Rs 37.2 bn Profit attributable FY24: Rs 4.6 bn FY24 Revenue FY25: Rs 43.1 bn Profit attributable FY25: Rs 6.4 bn FY25
Margins Gross margin Operating margin Net margin
Margins 42% 21% 0% Gross margin FY16: 28.1% Gross margin FY17: 37.4% Gross margin FY18: 29.6% Gross margin FY19: 30.6% Gross margin FY20: 26.8% Gross margin FY21: 27.5% Gross margin FY22: 17.4% Gross margin FY23: 20.4% Gross margin FY24: 34.5% Gross margin FY25: 39.1% Operating margin FY16: 15.5% Operating margin FY17: 12.9% Operating margin FY18: 11.0% Operating margin FY19: 11.4% Operating margin FY20: 9.2% Operating margin FY21: 11.9% Operating margin FY22: 3.8% Operating margin FY23: 5.4% Operating margin FY24: 18.1% Operating margin FY25: 23.1% Net margin FY16: 10.1% Net margin FY17: 8.5% Net margin FY18: 7.2% Net margin FY19: 7.7% Net margin FY20: 6.4% Net margin FY21: 8.8% Net margin FY22: 1.2% Net margin FY23: 3.1% Net margin FY24: 12.3% Net margin FY25: 14.8% FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25
Cash flow Operating cash flow Capex Free cash flow
Cash flow Rs 8 bn -Rs 3 bn Operating cash flow FY16: Rs 971.6 mn Capex FY16: -Rs 71.0 mn Free cash flow FY16: Rs 900.6 mn FY16 Operating cash flow FY17: Rs 646.4 mn Capex FY17: -Rs 28.4 mn Free cash flow FY17: Rs 618.0 mn FY17 Operating cash flow FY18: -Rs 342.9 mn Capex FY18: -Rs 314.8 mn Free cash flow FY18: -Rs 657.7 mn FY18 Operating cash flow FY19: Rs 1.4 bn Capex FY19: -Rs 524.8 mn Free cash flow FY19: Rs 828.0 mn FY19 Operating cash flow FY20: Rs 2.9 bn Capex FY20: -Rs 851.3 mn Free cash flow FY20: Rs 2.1 bn FY20 Operating cash flow FY21: Rs 1.8 bn Capex FY21: -Rs 543.3 mn Free cash flow FY21: Rs 1.2 bn FY21 Operating cash flow FY22: Rs 1.2 bn Capex FY22: -Rs 503.4 mn Free cash flow FY22: Rs 715.1 mn FY22 Operating cash flow FY23: Rs 2.6 bn Capex FY23: -Rs 1.8 bn Free cash flow FY23: Rs 798.7 mn FY23 Operating cash flow FY24: Rs 7.7 bn Capex FY24: -Rs 3.2 bn Free cash flow FY24: Rs 4.5 bn FY24 Operating cash flow FY25: Rs 6.3 bn Capex FY25: -Rs 2.0 bn Free cash flow FY25: Rs 4.3 bn FY25

Valuation

HALEON valuation at today's price

Price to earnings (P/E)
12.4×
EPS Rs 56.41 (TTM to Jun 2026)
Price to book (P/B)
5.02×
Book value Rs 138.76 (Quarter to Jun 2026)
Dividend yield
4.3%
DPS Rs 30.00 (FY2025)
Earnings yield
8.1%
EPS ÷ price

At the closing price of Rs 697.10 on 13 Nov 2026. P/E and P/B are not shown when earnings or book value are negative.

Sector peers

HALEON vs Pharmaceuticals companies

Largest companies in the sector at today's prices
Company Market cap P/E P/B Yield ROE 3-yr growth
HALEON Rs 81.6 bn 12.4× 5.02× 4.3% 47.6% 16.2%
GLAXO Rs 107.1 bn 10.3× 3.11× 5.1% 32.4% 16.3%
ABOT Rs 97.9 bn 11.4× 3.05× 4.0% 28.8% 15.2%
HINOON Rs 50.8 bn 12.8× 3.95× 5.2% 32.3% 20.5%
AGP Rs 43.8 bn 11.7× 2.92× 5.1% 25.9% 26.0%
HPL Rs 38.5 bn 10.3× 4.50× 6.0% 38.6% 18.6%
FEROZ Rs 15.8 bn 16.1× 1.19× 1.5% 7.6% 27.9%
CPHL Rs 14.5 bn 18.3× 1.34× 0.0% 7.3% 4.3%
MACTER Rs 12.0 bn 17.7× 2.87× 0.0% 17.4% 20.7%

All Pharmaceuticals companies, medians and leaders →

Rankings

Where HALEON ranks on PSX

Compare

Compare HALEON with

Analyses & signals 0

Win rate — · 0 closed signals · average return —

No analyses published for HALEON yet.

HALEON: frequently asked questions

What is HALEON's EPS?

Haleon Pakistan Limited reported basic earnings per share of Rs 54.45 for FY2025 (Jan – Dec 2025). Over the trailing twelve months (TTM to Jun 2026) EPS was Rs 56.41.

What is HALEON's P/E ratio?

At the closing price of Rs 697.10 on 13 Nov 2026, HALEON trades at a P/E of 12.4× based on EPS of Rs 56.41 (TTM to Jun 2026).

Does HALEON pay dividends?

Yes. Haleon Pakistan Limited declared a dividend of Rs 30.00 per share for FY2025. It has paid a dividend in each of the last 2 years. At Rs 697.10 that is a dividend yield of 4.3%.

What was HALEON's revenue and profit in FY2025?

Haleon Pakistan Limited reported revenue of Rs 43.1 bn and profit attributable to shareholders of Rs 6.4 bn for FY2025 (Jan – Dec 2025).

What is HALEON's book value per share?

Haleon Pakistan Limited's book value per share was Rs 126.41 at the end of FY2025. The shares trade at 5.02× book value.

How has HALEON's share price performed?

HALEON's share price is down 16.4% year to date (KSE-100: +2.2%), down 14.7% over one year (KSE-100: +10.7%) and up 171.0% over five years (KSE-100: +288.8%), as of 13 Nov 2026. These are price returns; dividends are not included.

Information only, not investment advice.